Clinical Trials on Urinary Stent

Total 59580 results

Kliniken Ludwigsburg-Bietigheim gGmbH
Klinikum Ludwigshafen; Universitätsmedizin Mannheim

Unknown

Comparison of a Plastic Stent Without Central Lumen With Self Expandable Metal Stents in Patients With Malignant Distal Biliary Obstruction (VIADUCT)

To Evaluate Patency of the Viaduct Stent in Comparison to Metal Stents

Germany
North Texas Veterans Healthcare System

Terminated

Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT) (STRUT-OCT)

Optical Coherence Tomography (OCT) | Percutaneous Coronary Intervention (PCI) | Drug Eluting Stents (DES) | Uncovered and Malapposed Stent Struts

United States
University Hospital of Patras

Not yet recruiting

REtrospective Analysis on the Use of COvered Stents for the Treatment of the Dysfunctional Vascular Access (RECOVA)

Study Focuses on the Use of Covered Stents (Stent Grafts) for the Treatment of Dysfunctional Vascular Access of Hemodialysis Patients
Seoul National University Hospital
Dong-A ST Co., Ltd.

Completed

The Effect of Naftopidil for the Double-J Stent Discomfort

Disorder of Urinary Stent

Korea, Republic of
Urmia University of Medical Sciences

Completed

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

Disorder of Urinary Stent

Iran, Islamic Republic of
Azienda Ospedaliera Città della Salute e della...
University Hospital, Zürich

Completed

veRy Thin Stents for Patients With Left mAIn or bifurcatioN in Real Life: the RAIN a Multicenter Study (RAIN)

Left Main Coronary Artery Disease | Stent Thrombosis | Stent Restenosis | Coronary Bifurcations | Very Thin Stents

Italy
Mansoura University

Recruiting

Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms

Ureteral Stent | Stent Related Symptoms

Egypt
Phoenix Children's Hospital

Unknown

Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Disorder of Urinary Stent
University of California, Irvine

Terminated

Randomization of Botox for Stent Pain and Irritative Voiding Symptoms

Lower Urinary Tract Discomfort | Stent Pain

United States
Yanbin Li

Not yet recruiting

Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

Stent Restenosis
Mayo Clinic

Enrolling by invitation

Optimal Stent Duration After Ureteroscopy

Ureteral Stent

United States, Canada
Devicare S.L.
Clever Instruments S.L.

Completed

Combined Use of a Medical Device and a Dietary Complement in Patient Urinary pH Control in Patients With an Implanted Double J Stent.

Stent Complications

Spain
Semmelweis University Heart and Vascular Center

Recruiting

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis (OPEN-ISR)

Coronary Stent Restenosis

Hungary
Boston Scientific Corporation

Active, not recruiting

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) (AGENT IDE)

In-Stent Restenosis

United States
North Texas Veterans Healthcare System

Terminated

Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac Surgery

Coronary Stent Occlusion

United States
Klinikum Coburg

Unknown

Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

In-Stent Restenosis

Germany
Rigshospitalet, Denmark
University of Copenhagen

Recruiting

Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia (COMESS)

Mesenteric Ischemia | Stent Thrombosis | Stent Restenosis | Stent-Graft Restenosis | Stent-Graft Thrombosis | Stent-Graft Stenosis | Stent Occlusion | Bowel; Ischemic | Superior Mesenteric Atherosclerosis | Mesenteric Artery Stenosis

Denmark
Fifth Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Detection of Ureteral Stent Encrustation

Ureteral Stent-Related Symptom
Second Affiliated Hospital, School of Medicine,...
West China Hospital; The Third Xiangya Hospital of Central South University; Shanghai... and other collaborators

Unknown

Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis

Coronary In-stent Restenosis

China
Medical University of Vienna

Completed

Late Acquired Malaposition and Different Polymers

Late Acquired Stent Malaposition

Austria
Assiut University

Not yet recruiting

Role of Novel Biomarkers Associated With In-stent Restenosis After Percutaneous Coronary Intervention

In-stent Restenosis
NYU Langone Health

Withdrawn

Comparison of Stent Suturing Versus OTSC Stentfix

Esophageal Stent Fixation

United States
Luzerner Kantonsspital

Unknown

Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis

In-stent Restenosis
University of Minnesota

Completed

Alfuzosin Hydrochloride to Relieve Ureteral Stent Discomfort

Ureteral Stent Discomfort

United States
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)

In-Stent Restenosis

Spain
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
ReFlow Medical, Inc.

Not yet recruiting

A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)

In-stent Restenosis
Yonsei University

Recruiting

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR) (GENISPIRE)

In-stent Restenosis

Korea, Republic of
University Hospital, Clermont-Ferrand
Abbott; Corelab ISIT

Completed

Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT (RESTO)

In-stent Restenosis

France, Belgium, Switzerland
Chansu Vascular Technologies

Active, not recruiting

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

In-stent Restenosis

Spain, France, Georgia, Lithuania
Ambu Inc.
Ambu A/S

Completed

Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy

Cystoscopy | Ureteral Stent

United States
RenJi Hospital

Completed

In-stent Restenosis and Pericoronary Fat Attenuation Index

In-stent Restenosis

China
Medical University of Silesia
Wojciech Wojakowski

Completed

DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry) (DEB-DRAGON)

In Stent Restenosis

Poland
Shandong Branden Med.Device Co.,Ltd
Fudan University

Unknown

Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter

In-stent Restenosis

China
Dr .S.B.PATANKAR

Completed

Study of Herbmed Plus in Ureteral Stent Discomfort

Ureteral Stent Discomfort

India
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Medical University of Warsaw
KCRI

Unknown

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (ISRII)

In-Stent Restenosis

Poland
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
NYU Langone Health

Completed

Eponychial Stent Study

Nail Bed Injury | Eponychial Stent

United States
Seoul National University Hospital

Unknown

Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -

In-stent Restenosis Lesion

Korea, Republic of
Midwest Cardiovascular Research Foundation

Completed

JetStream Atherectomy for the Treatment of In-stent Restenosis (JET-ISR)

Femoropopliteal In-stent Restenosis

United States
Cantonal Hospital of St. Gallen

Completed

Reduction of Stent Associated Morbidity by Minimizing Stent Material.

Ureteral Stent Related Morbidity

Switzerland
Cantonal Hospital of St. Gallen

Completed

Assessment of Longterm Ureteral Stenting

Longterm Indwelling Ureteral Stent

Switzerland
Stentys

Unknown

Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice (WIN)

Coronary Self Expanding Stent

Netherlands, Switzerland
Spanish Society of Cardiology
Abbott Medical Devices; Terumo Medical Corporation; Fundación de Investigación... and other collaborators

Unknown

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) (RIBS VI)

Coronary In-stent Restenosis

Spain
Spectranetics Corporation
Yale University

Withdrawn

First in Human Study of Winsor Laser Catheter: A Prospective Registry to Evaluate The Safety and Performance of the Winsor Laser Catheter in the Treatment of In-Stent Restenosis

Femoropopliteal In-Stent Restenosis

Colombia
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis

Coronary In-stent Restenosis

China
University Hospital, Saarland

Completed

Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter

In-stent Arterial Restenosis

Germany, Brazil
University Health Network, Toronto

Unknown

Paclitaxel Eluting Balloon for SFA In-stent Restenosis

In-stent Arterial Restenosis

Canada
Yonsei University

Unknown

Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation (statin)

Drug-eluting Stent (DES)

Korea, Republic of

Clinical Trials on Urinary Stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations